ZA756192B - Novel cephalosporin compounds - Google Patents

Novel cephalosporin compounds

Info

Publication number
ZA756192B
ZA756192B ZA00756192A ZA756192A ZA756192B ZA 756192 B ZA756192 B ZA 756192B ZA 00756192 A ZA00756192 A ZA 00756192A ZA 756192 A ZA756192 A ZA 756192A ZA 756192 B ZA756192 B ZA 756192B
Authority
ZA
South Africa
Prior art keywords
cephalosporin compounds
novel cephalosporin
novel
compounds
cephalosporin
Prior art date
Application number
ZA00756192A
Other languages
English (en)
Inventor
D Berges
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of ZA756192B publication Critical patent/ZA756192B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
ZA00756192A 1974-12-27 1975-09-30 Novel cephalosporin compounds ZA756192B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/536,759 US3989694A (en) 1974-12-27 1974-12-27 7-Acyl-3-(substituted triazolyl thiomethyl)cephalosporins

Publications (1)

Publication Number Publication Date
ZA756192B true ZA756192B (en) 1976-09-29

Family

ID=24139827

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00756192A ZA756192B (en) 1974-12-27 1975-09-30 Novel cephalosporin compounds

Country Status (14)

Country Link
US (2) US3989694A (da)
JP (1) JPS5188989A (da)
AU (1) AU8789275A (da)
BE (1) BE837071A (da)
CA (1) CA1085822A (da)
CH (1) CH622262A5 (da)
DE (1) DE2558024A1 (da)
ES (2) ES442100A1 (da)
FR (2) FR2313068A1 (da)
GB (2) GB1539518A (da)
IE (1) IE43127B1 (da)
IT (1) IT1051939B (da)
NL (1) NL7513872A (da)
ZA (1) ZA756192B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS612674B2 (da) * 1974-06-20 1986-01-27 Meiji Seika Co
US4172196A (en) * 1974-09-03 1979-10-23 Bristol-Myers Company Certain 7-α-substituted-α-hydroxyacetamido-3-(1-carboxymethyltetrazol-5-yl-thiomethyl)-3-cephem-4-carboxylic acids
US4182863A (en) * 1974-09-03 1980-01-08 Bristol-Myers Company 7-Amino-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
US3989694A (en) * 1974-12-27 1976-11-02 Smithkline Corporation 7-Acyl-3-(substituted triazolyl thiomethyl)cephalosporins
IL49183A0 (en) * 1975-03-27 1976-05-31 Pfizer Novel cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
US4183925A (en) * 1975-03-27 1980-01-15 Pfizer Inc. 7-Aminophenylacetamido-Δ3 -cephem antibacterial agents and method of use
US4220644A (en) * 1976-05-03 1980-09-02 Smithkline Corporation 7-Acylamino-3-(substituted tetrazolyl thiomethyl) cephalosporins
US4082912A (en) * 1976-06-30 1978-04-04 Bristol-Myers Company Certain 7-acylamido-3-(2-carboxyalkyl-2,3-dihydro-s-triazolo[4,3-b]pyridazin-3-on-6-ylmethyl)-3-cephem-4-carboxylic acids their salts and easily hydrolyzed esters
JPS5321191A (en) * 1976-08-10 1978-02-27 Shionogi & Co Ltd 7-arylmalonamidocephem derivatives
US4057631A (en) * 1976-09-02 1977-11-08 Smithkline Corporation 7-(α-Substituted phenylacetamido)-3-(1-carboxymethylthioethyltetrazolyl-5-thiomethyl)-3-cephem-4-carboxylic acids
US4083975A (en) * 1976-09-24 1978-04-11 Smithkline Corporation 7-Acylamino-3-(3-sulfomethyl-1,2,4-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acids
US4174324A (en) * 1977-06-30 1979-11-13 Smithkline Corporation 3-(Carboxymethyl)thio-1H-1,2,4-triazol-5-thione
US4117124A (en) * 1977-06-30 1978-09-26 Smithkline Corporation 7-Acylamino-3-[[3-(carboxymethyl)thio-1H-1,2,4-triazol-5-yl]thiomethyl]-3-cephem-4-carboxylic acids
US4197240A (en) * 1977-12-23 1980-04-08 Yeda Research And Development Co. Ltd. Penicillin derivatives
US4229575A (en) * 1978-02-27 1980-10-21 Richardson-Merrell Inc. 7-(2,3-Dihydrobenzo-5-furanyl)-acetamido cephalosporin derivatives
US4219648A (en) * 1978-03-06 1980-08-26 Richardson-Merrell Inc. 7-[[Amino(1,3-dihydrobenzo[c]thienyl)acetyl]amino]cephalosporin derivatives
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
PT87616B (pt) 1987-06-24 1992-09-30 Smithkline Beecham Corp Processo de preparacao de antagonistas do leucotrieno e de composicoes farmaceuticas

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL173169C (nl) 1969-10-27 1983-12-16 Fujisawa Pharmaceutical Co Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking en werkwijze voor het bereiden van het daarvoor benodigde cephalosporinederivaat.
US3759904A (en) * 1971-07-29 1973-09-18 Bristol Myers Co Ds and salts thereof 3 - (s-(1,2,3-triazole-5-yl)thiomethyl)-3 - cephem - 4-carboxylic aci7-(d-(alpha-amino-alpha-phenyl-, 2-thienyl- and 3-thienylacetamido))-
US3796801A (en) * 1971-11-04 1974-03-12 Smithkline Corp Method of combating enterobacter infections
BE793037A (fr) * 1971-12-23 1973-06-20 Fujisawa Pharmaceutical Co Procede de preparation de derives d'acide 7-acylamino-3-substitue-3-cephem-4-carboxylique et nouveaux produits ainsi obtenus
US3813388A (en) * 1972-01-31 1974-05-28 L Crast 7-(d-(alpha-amino-alpha-phenyl-,2-thienyl-and 3-thienyl-acetamido))-3-(s-(2-methyl-1,2,3-triazole-4-yl)thiomethyl)-3-cephem-4-carboxylic acids
US4007173A (en) 1973-05-07 1977-02-08 Smithkline Corporation α-amino-α-(ureidophenyl)acetamidocephalosporins
JPS5653557B2 (da) * 1973-10-15 1981-12-19
GB1476981A (en) * 1974-06-05 1977-06-16 Bristol Myers Co Substituted penicillanic acids
US3989694A (en) * 1974-12-27 1976-11-02 Smithkline Corporation 7-Acyl-3-(substituted triazolyl thiomethyl)cephalosporins

Also Published As

Publication number Publication date
IE43127L (en) 1976-06-27
GB1539518A (en) 1979-01-31
AU8789275A (en) 1977-06-30
US4142046A (en) 1979-02-27
US3989694A (en) 1976-11-02
CH622262A5 (da) 1981-03-31
GB1539517A (en) 1979-01-31
NL7513872A (nl) 1976-06-29
FR2313068B1 (da) 1979-09-28
FR2313068A1 (fr) 1976-12-31
FR2303807A1 (fr) 1976-10-08
IT1051939B (it) 1981-05-20
CA1085822A (en) 1980-09-16
FR2303807B1 (da) 1980-10-24
ES456340A1 (es) 1978-01-16
ES442100A1 (es) 1977-07-01
BE837071A (fr) 1976-06-24
IE43127B1 (en) 1980-12-31
DE2558024A1 (de) 1976-07-08
JPS5188989A (da) 1976-08-04

Similar Documents

Publication Publication Date Title
PH14161A (en) Thiazolylacetamido compounds
ZA756192B (en) Novel cephalosporin compounds
GB1516331A (en) Aminotetralol compounds
ZA757892B (en) Thiazolylacetamido compounds
ZA756532B (en) Novel cephalosporin compounds
IL47802A0 (en) Novel cephalosporin compounds
IE40636L (en) N-bromoalkylazetidinones; cephalosporin intermediates
HK45081A (en) Tetrazolethiomethyl cephalosporin compounds
AU8216875A (en) Heterocyclic compounds
ZA755654B (en) N-acylamino-alpha-arylacetamido cephalosporins
GB1487658A (en) Cephalosporin derivative
IE41150L (en) Cephalosporin derivatives
PH12494A (en) 1-acyl-4(o-halophenyl)-3-thiosemicarbazide compounds
GB1518987A (en) Heterocyclic compounds
PH14552A (en) Heterocyclic compounds
ZA752821B (en) Substituted benzenemthantol compounds
AU8451975A (en) 3-heterothio-7-ureido cephalosporins
ZA756291B (en) Antibiotic compounds
GB1519505A (en) Heterocyclic compounds
ZA754959B (en) Novel cephalosporin compounds
ZA753621B (en) Penicillins
GB1486272A (en) Cephalosporins
IE43128L (en) Cephalosporin compounds
ZA753647B (en) Aminotetralol compounds
AU8597975A (en) Hydrodipyrano - phthalazine compounds